What is NDC 62332-020?

62332-020 is the product NDC for Meprobamate, Meprobamate 400 mg/1 tablet, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Meprobamate?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Meprobamate NDC 62332-020 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-020Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0020Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-020-30	6233200203062332002030	30 TABLET in 1 BOTTLE (62332-020-30)Marketed from Mar 31, 2016
62332-020-31	6233200203162332002031	100 TABLET in 1 BOTTLE (62332-020-31)Marketed from Mar 31, 2016
62332-020-91	6233200209162332002091	1000 TABLET in 1 BOTTLE (62332-020-91)Marketed from Mar 31, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Meprobamate
Generic name (nonproprietary): meprobamate
Active ingredients: Meprobamate — 400 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.NDC labeler code 62332
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090122
Marketing start: Mar 31, 2016
Listing expires: Dec 31, 2027
DEA schedule: CIV
Identifiers: Product ID 62332-020_a2f676cd-53ae-4401-9553-a7d70c79bb0aSPL ID a2f676cd-53ae-4401-9553-a7d70c79bb0aSPL set ID 3b255bcd-0218-44f8-830b-971f5ec45276RxCUI 197928, 197929UNII 9I7LNY769Q

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332002030 followed by a unit qualifier and the quantity

Package 62332-0020-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic. The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62332-020

What is NDC 62332-020?: 62332-020 is the product NDC for Meprobamate, Meprobamate 400 mg/1 tablet, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Meprobamate.
What is the active ingredient?: Meprobamate.
Who is the labeler?: Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Meprobamate?: 5 other product NDCs are listed under this name. See all Meprobamate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Meprobamate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Meprobamate	Meprobamate 200 mg/1	TabletOral	Cipla USA Inc.	69097-974	69097-0974-07
Meprobamate	Meprobamate 400 mg/1	TabletOral	Cipla USA Inc.	69097-975	69097-0975-07
Meprobamate	Meprobamate 200 mg/1	TabletOral	Alembic Pharmaceuticals Inc.	62332-019	62332-0019-3062332-0019-3162332-0019-91
Meprobamate	Meprobamate 200 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-019	46708-0019-3046708-0019-7146708-0019-91
Meprobamate	Meprobamate 400 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-020	46708-0020-3046708-0020-7146708-0020-91

Other NDCs under ANDA 090122

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090122
Product	Strength	Form · route	Labeler	Product NDC
Meprobamate	Meprobamate 200 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-019
Meprobamate	Meprobamate 400 mg/1	TabletOral	Alembic Pharmaceuticals Limited	46708-020
Meprobamate	Meprobamate 200 mg/1	TabletOral	Alembic Pharmaceuticals Inc.	62332-019